Dialysis limitations. Dialysis limitations. (A) Recent data from observational studies and randomized, clinical trials indicate significant limitations.

Slides:



Advertisements
Similar presentations
Significance Testing.  A statistical method that uses sample data to evaluate a hypothesis about a population  1. State a hypothesis  2. Use the hypothesis.
Advertisements

 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.
Medical Technology and Practice Patterns Institute 4733 Bethesda Ave., Suite #510 Bethesda, MD Phone: Fax: Comparison of.
The DVD Trial. Source Reinecke H, Fobker M, Wellmann J, et al. A randomized controlled trial comparing hydration therapy to additional hemodialysis or.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.
Renal Replacement Therapy for Prevention of Contrast- induced Acute Kidney Injury: A Meta-analysis of Randomized Controlled Trials Source Song K, Jiang.
Optimization of pre-ESRD care: The key to improved dialysis outcomes
The HEMO Study Hemodialysis (HEMO) Study Reference
Quantification and Dosing of Renal Replacement Therapy in Acute Kidney Injury: A Reappraisal Blood Purif 2017;44: DOI: / Fig.
The ADEMEX Trial Adequacy of PD in Mexico Reference
Treatment of acute renal failure
Volume 66, Issue 4, Pages (October 2004)
Adjusted odds ratio 95% CI Diagnostic angiography PCI CABG
Relationship between serum sodium after racing and the weight change (in %) during exercise in 2135 athletes who competed in endurance events. •, asymptomatic.
Fan et al. Am J Nephrol 2017;45:   (DOI: / )
Intensive hemodialysis—keeping the faith
Suggested approach to patients with dabigatran-associated bleeding
Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.
Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.
Mechanism by which negative sodium and water balance may improve myocardial and renal function in CHF. [Reprinted from J Am Coll Cardiol, vol. 47, Schrier.
Volume 84, Issue 5, Pages (November 2013)
End-stage renal disease in developing countries
Volume 64, Issue 6, Pages (December 2003)
Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Intensive hemodialysis—keeping the faith
Fluid overload and residual renal function in peritoneal dialysis: the proof of the pudding is in the eating  Wim Van Biesen, Achim Jörres  Kidney International 
Patterns of mortal risk among eKt/V quintiles in the HEMO study for (A) 1 yr of follow-up and (B) after 1 yr. Patterns of mortal risk among eKt/V quintiles.
Volume 66, Issue 4, Pages (October 2004)
Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought  Nicolas Rognant, Maurice Laville  Kidney.
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
Volume 65, Issue 2, Pages (February 2004)
Treatment of acute renal failure
Benefits of preserving residual renal function in peritoneal dialysis
Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial  Ramon Paniagua, Dante Amato, Edward Vonesh,
Nutritional requirements in maintenance hemodialysis
Body size and outcomes on peritoneal dialysis in the United States
Blood pressure targets in hemodialysis patients
Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Volume 65, Issue 4, Pages (April 2004)
Volume 60, Issue 3, Pages (September 2001)
The Danish Renal Biopsy Register
The Use of Vaccines in Adult Patients With Renal Disease
Kaplan–Meier curve for technique survival censored for death, transplantation, and program exit for patient choice for all individuals commencing home.
(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E
Ionized-to-total magnesium (Mg) and calcium (Ca) ratios are lower in patients on hemodialysis than those in patients not on dialysis. Ionized-to-total.
PTH response to the predialysis serum calcium concentration in hemodialysis patients with severe (A), moderate (B), and mild (C) hyperparathyroidism. PTH.
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Six-month change in proteinuria predicts risk for ESRD
Combination angiotensin-converting enzyme inhibitor (ACEI)/angiotensin II receptor blocker (ARB) reduced risk for renal end point versus ACEI or ARB. Effect.
Distribution of vascular access type (2002–2011) among countries with stable or decreasing catheter burden over time. Distribution of vascular access type.
The figure shows lack of strong evidence for vitamin D therapy to prevent cardiovascular disease in CKD. Although epidemiologic studies suggest a relationship.
Mortality caused by cardiovascular disease (A) and sepsis (B) of patients with end-stage renal disease (ESRD) treated by dialysis compared with the general.
Cumulative mortality risk in patients with 48-h blood urea nitrogen (BUN) levels of ≥8 mg/dl or
Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.
Gentamicin plasma and peritoneal dialysate concentrations in peritoneal dialysis patients with peritonitis. Gentamicin plasma and peritoneal dialysate.
New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.
A total of 150 dialysis patients washed out of previous antihypertensive therapy (Pretreatment) and underwent periodic evaluation of aortic PWV (line indicating.
As the patient nears the end of life (dashed arrow), there is an increasing focus on symptom control and patient goals of care and a shift in the approach.
Cumulative survival curves for deceased-donor transplant recipients who were older than 70 yr and similarly aged dialysis patients who were on the waiting.
A simplified schematic representation of muscle wasting and weakness leading to decreased physical performance in patients with ESRD. In addition to specific.
Significant correlation between the initial urine osmolality (Uosm T0) and the variation in plasma sodium (DPNa) after 2 L of isotonic saline in 17 patients.
Survival among hemodialysis patients by geographic region in DOPPS 3 (2005–2008), with and without adjustments for patient mix differences. Survival among.
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Mean number of dialysis sessions per patient for which intradialytic hypotension–related nursing interventions were required during the first 2 wk and.
Perception of indications for referral to a nephrologist among internal medicine residents according to the postgraduate year (PGY). Perception of indications.
Role of decreased baroreceptor sensitivity, and activation of RAAS and SNS in expansion of water and sodium retention as well as worsening HF. [Reprinted.
Distribution of facility mean treatment time, by DOPPS region and phase. Distribution of facility mean treatment time, by DOPPS region and phase. Restricted.
Presentation transcript:

Dialysis limitations. Dialysis limitations. (A) Recent data from observational studies and randomized, clinical trials indicate significant limitations with respect to the effect of conventional dialysis therapy on patient outcomes. Data from the US Renal Data System indicate that risk-adjusted all-cause mortality for hemodialysis patients has not changed substantively over the past decade (reprinted from reference [5] with permission). (B) Furthermore, the risk-adjusted mortality of long-term dialysis (5+ yr vintage) has been increasing rather than decreasing over time (reprinted from reference [5] with permission). Both the HEMO Study (C; reprinted from reference [6] with permission) in hemodialysis patients and the ADEMEX Study (D; reprinted from reference [7] with permission) in peritoneal dialysis patients do not support the hypothesis that increasing dose of dialysis will improve patient survival. These data suggest a threshold–plateau relationship between clinical benefit and the dose of conventional dialysis. Jonathan Himmelfarb CJASN 2006;1:896-902 ©2006 by American Society of Nephrology